Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes

Hyperglycemia and hyperlipidemia are both risk factors for the development of various complications in patients with type 2 diabetes mellitus. Colesevelam hydrochloride is a novel agent that can improve both hypercholesterolemia and hyperglycemia in such patients. It is an orally administered bile a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekhri, Kavita, Saha, Lekha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Fast-track Publication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657969/
https://www.ncbi.nlm.nih.gov/pubmed/23776789
http://dx.doi.org/10.4103/2229-516X.91157
_version_ 1782270197840740352
author Sekhri, Kavita
Saha, Lekha
author_facet Sekhri, Kavita
Saha, Lekha
author_sort Sekhri, Kavita
collection PubMed
description Hyperglycemia and hyperlipidemia are both risk factors for the development of various complications in patients with type 2 diabetes mellitus. Colesevelam hydrochloride is a novel agent that can improve both hypercholesterolemia and hyperglycemia in such patients. It is an orally administered bile acid sequestrant with high capacity for binding bile acids. This drug can offer potential new diabetes treatment along with other drugs.
format Online
Article
Text
id pubmed-3657969
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36579692013-06-17 Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes Sekhri, Kavita Saha, Lekha Int J Appl Basic Med Res Fast-track Publication Hyperglycemia and hyperlipidemia are both risk factors for the development of various complications in patients with type 2 diabetes mellitus. Colesevelam hydrochloride is a novel agent that can improve both hypercholesterolemia and hyperglycemia in such patients. It is an orally administered bile acid sequestrant with high capacity for binding bile acids. This drug can offer potential new diabetes treatment along with other drugs. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3657969/ /pubmed/23776789 http://dx.doi.org/10.4103/2229-516X.91157 Text en Copyright: © International Journal of Applied and Basic Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Fast-track Publication
Sekhri, Kavita
Saha, Lekha
Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
title Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
title_full Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
title_fullStr Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
title_full_unstemmed Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
title_short Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
title_sort colesevelam hydrochloride: a novel agent in patients with type 2 diabetes
topic Fast-track Publication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657969/
https://www.ncbi.nlm.nih.gov/pubmed/23776789
http://dx.doi.org/10.4103/2229-516X.91157
work_keys_str_mv AT sekhrikavita colesevelamhydrochlorideanovelagentinpatientswithtype2diabetes
AT sahalekha colesevelamhydrochlorideanovelagentinpatientswithtype2diabetes

Ejemplares similares